Investors.csl.com

Global Biotechnology Company CSL

WEBWe have announced our 2024 Half Year Financial Results for the period ending 31 st December 2023. Announcement Information was released on Tuesday, 13 th February …

Actived: 8 days ago

URL: https://investors.csl.com/#!

Annual Reports Global Biotechnology Company CSL

WEBA strong year with underlying profit (NPATA) of US$2.61 billion for the 12 months ended 30 June 2023, up 20% on a constant currency 1 basis when compared to the prior …

Category:  Health Go Health

Health, Safety & Wellbeing CSL

WEBThe health and wellbeing of our employees is a top priority at CSL, and we have implemented numerous programs to enhance our support of employees’ physical, …

Category:  Health Go Health

Sustainability Global Biotechnology Company CSL

WEBCSL is committed to fostering a healthier world. Our vision is a sustainable future for all our stakeholders, inspired by innovative science and a values-driven culture. We have …

Category:  Health Go Health

Presentations Global Biotechnology Company CSL

WEBCSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Together they help ensure people everywhere get the treatments they need.

Category:  Health Go Health

Investor FAQs Global Biotechnology Company CSL

WEBThe Commonwealth Serum Laboratories was established in Australia in 1916 to service the health needs of a nation isolated by war. Over the ensuing years CSL provided …

Category:  Health Go Health

Financials Global Biotechnology Company CSL

WEBFinancials. -. Half Year Results 2024. Half Year Results 2024 Webcast Recording. CSL Half Year Results Investors Presentation. ASX Half Year Information. 2023. 2024. CSL's …

Category:  Health Go Health

Top 20 Shareholders Global Biotechnology Company CSL

WEBA live view of the top 20 largest shareholders invested in CSL

Category:  Health Go Health

Shareholder Services Global Biotechnology Company CSL

WEBCSL’s ADR information with BNY Mellon can also be viewed at www.bnymellon.com. ADR holders seeking information on their shareholding should contact: BNY Mellon …

Category:  Health Go Health

CSL Enters Licensing Agreement with Arcturus Therapeutics …

WEBPage 2 2 November 2022 . and commercial milestones along with royalties/profit sharing on future product sales. CSL’s Head of R&D and Chief Medical Officer, Dr Bill Mezzanotte …

Category:  Medical Go Health

Debt Information Global Biotechnology Company CSL

WEBFunding and liquidity risk. For more information please view page 142 of CSL’s 2023 Annual Report.

Category:  Health Go Health

Share Price Chart Global Biotechnology Company CSL

WEBShare Price Chart. Below are share charts depicting the Company's performance over different time periods. The trend charts update each morning.

Category:  Health Go Health

Share Price Global Biotechnology Company CSL

WEBCSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Together they help ensure people everywhere get the treatments they need.

Category:  Health Go Health

Financial Calendar Global Biotechnology Company CSL

WEBFinancial Calendar | Global Biotechnology Company | CSL. Investors > Financial Calendar. Filter by Year: 2024 2023 2022 2021 2020. 14 Feb 2023 Time: 11:00 to 12:00.

Category:  Health Go Health

CSL ANNUAL REPORT 2020/21

WEBFor immediate release 3 September. 2021 . CSL ANNUAL REPORT 2020/21 Melbourne, Australia – CSL (ASX:CSL; USOTC:CSLLY). The CSL Board of Directors is pleased to …

Category:  Health Go Health